News

Pharmabiz18h
Pharmexcil announces product enquiry for itraconazole supply to Dubai based buyer
Pharmexcil announces product enquiry for itraconazole supply to Dubai based buyer: Shardul Nautiyal, Mumbai Friday, July 25, ...
Pharmabiz8h
Health Canada approves Clearside Biomedical’s Xipere for suprachoroidal treatment for uveitic macular edema
Health Canada approves Clearside Biomedical’s Xipere for suprachoroidal treatment for uveitic macular edema: Alpharetta, Georgia Friday, July 25, 2025, 18:00 Hrs [IST] Clearside ...
Pharmabiz11h
Novavax's H5N1 avian pandemic influenza vaccine candidate demonstrates immunogenicity in preclinical study
Novavax's H5N1 avian pandemic influenza vaccine candidate demonstrates immunogenicity in preclinical study: Gaithersburg, Maryland Friday, July 25, 2025, 15:00 Hrs [IST] Novavax, ...
Pharmabiz13h
India-UK free trade agreement to benefit pharma, medical devices segment, say experts
India-UK free trade agreement to benefit pharma, medical devices segment, say experts: Our Bureau, New Delhi Friday, July 25, 2025, 12:40 Hrs [IST] The India-UK free trade agreeme ...
Pharmabiz13h
LenioBio secures EUR 3.7 million of EU4Health funding to develop ALiCE for cost-effective and rapid production of protein-based medicines
LenioBio secures EUR 3.7 million of EU4Health funding to develop ALiCE for cost-effective and rapid production of protein-based medicines: Dusseldorf, Germany Friday, July 25, 202 ...
Pharmabiz14h
Philips announces major advancement in image-guided navigation for prostate cancer care with the US FDA 510(k) clearance of Philips UroNav version
Philips announces major advancement in image-guided navigation for prostate cancer care with the US FDA 510(k) clearance of Philips UroNav version: Amsterdam, the Netherlands Frid ...
Pharmabiz10h
Sygnature Discovery completes major enhancement of high-throughput chemistry facilities following £1 million investment
Sygnature Discovery completes major enhancement of high-throughput chemistry facilities following £1 million investment: Nottingham, UK Friday, July 25, 2025, 16:00 Hrs [IST] Syg ...
Pharmabiz15h
US FDA extends the review period for GSK’s Blenrep combinations to treat relapsed/refractory multiple myeloma
US FDA extends the review period for GSK’s Blenrep combinations to treat relapsed/refractory multiple myeloma: London, UK Friday, July 25, 2025, 11:00 Hrs [IST] GSK plc announce ...
Pharmabiz12h
OSR Holdings signs term sheet to acquire South Korea-based noninvasive glucose monitoring technology company, Woori IO
OSR Holdings signs term sheet to acquire South Korea-based noninvasive glucose monitoring technology company, Woori IO: Bellevue, Washington Friday, July 25, 2025, 14:00 Hrs [IST] ...
Pharmabiz18h
NPPA directs stakeholders to align MRP of non-scheduled formulations as per DPCO provisions
NPPA directs stakeholders to align MRP of non-scheduled formulations as per DPCO provisions: Gireesh Babu, New Delhi Friday, July 25, 2025, 08:00 Hrs [IST] The National Pharmaceut ...
Pharmabiz9h
Scientist.com expands Tumour Model Finder with XenoSTART’s highly relevant, patient-derived tumour models
Scientist.com expands Tumour Model Finder with XenoSTART’s highly relevant, patient-derived tumour models: San Diego Friday, July 25, 2025, 17:00 Hrs [IST] Scientist.com, the le ...
Pharmabiz18h
India shaping the future of global genomics with sound expertise in bioinformatics and NGS
India shaping the future of global genomics with sound expertise in bioinformatics and NGS: Nandita Vijayasimha, Bengaluru Friday, July 25, 2025, 08:00 Hrs [IST] India’s efforts ...